1/22
07:03 am
ACRS
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
Medium
Report
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
1/17
07:21 am
ACRS
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
1/11
08:12 am
ACRS
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) had its "neutral" rating re-affirmed by analysts at BTIG Research.
Low
Report
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) had its "neutral" rating re-affirmed by analysts at BTIG Research.
1/11
08:10 am
ACRS
Rating for ACRS
Low
Report
Rating for ACRS
12/29
10:06 am
ACRS
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Medium
Report
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.